RxDoctor Payments DataLook up a doctor →

Michelle Ehrlich, MD

Dermatology · Manhattan Beach, CANPI 1134244635

Payments from drug & device makers

$735,147in general payments, 2019–2025

Across 1,483 payments — averaging $495.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma Inc.$183K
  • Amgen$122K
  • Galderma Laboratories, L.p.$84K
  • Pfizer$83K
  • Arcutis Biotherapeutics, Inc.$78K
  • Incyte Corporation$66K
  • plus $119K from 41 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
LEO Pharma Inc.219$182,846
Amgen177$122,008
Galderma Laboratories, L.p.151$84,060
Pfizer138$82,553
Arcutis Biotherapeutics, Inc.101$78,097
Incyte Corporation88$66,357
Verrica Pharmaceuticals Inc.35$41,738
Bristol Myers Squibb47$17,812
Sun Pharmaceutical Industries Inc.42$16,303
Dermavant Sciences, Inc.51$14,870
Kowa Pharmaceuticals America, Inc.8$7,690
Ortho Dermatologics, A Division Of Bausch Health US, LLC20$5,028
Journey Medical Corporation24$2,104
AbbVie84$2,047
Botanix SB Inc8$1,632
Biofrontera Inc.2$1,525
Johnson & Johnson29$1,062
UCB, Inc.55$1,057
Mayne Pharma Commercial LLC95$1,000
Almirall LLC9$635
Sanofi11$608
Regeneron1$523
Promius Pharma LLC1$500
Medimetriks Pharmaceuticals, Inc.6$458
LEO Pharma AS4$411
Lilly USA, LLC9$218
Organon7$215
Revance Therapeutics, Inc.5$202
Musculoskeletal Transplant Foundation Inc.4$195
Alfasigma USA, Inc.5$183
Merz North America, Inc.6$176
Regeneron Healthcare Solutions, Inc.7$170
E.r. Squibb & Sons, L.L.C.5$147
Novartis9$139
EPI Health, LLC5$131
Sanofi-aventis U.S. LLC1$96
Boehringer Ingelheim1$51
Prugen, Inc. Pharmaceuticals1$47
Aclaris Therapeutics, Inc.2$47
Glenmark Therapeutics Inc.1$43
Mission Pharmacal Company3$40
Organogenesis Inc.1$38
Boston Scientific1$25
Exeltis, USA Inc.1$20
ANI Pharmaceuticals, Inc.1$17
Sandoz1$14
Dermira, Inc.1$11

How this compares

$735,147 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$60,836
Medicare patients
131
Services billed
1,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Manhattan Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →